The New York Times published a feature article that detailed a research effort to unravel the genetic underpinnings of cardiovascular disease. Members of one family with a history of heart-related deaths have agreed to participate in the study.

Today Ted A. Bass, M.D., FSCAI, announced that the focus of his term as the 36th President of the Society for Cardiovascular Angiography and Interventions will be to expand SCAI’s commitment to quality improvement in invasive and interventional cardiology. Dr. Bass was inducted at the SCAI 2013 Scientific Sessions, where he led a Town Hall-style discussion among attendees about the opportunities and challenges facing the specialty. 

Seven percent of patients implanted with subcutaneous implantable cardioverter-defibrillators (S-ICDs) experienced inappropriate shocks, according to an analysis of registry data presented May 9 at the Heart Rhythm Society (HRS) scientific sessions in Denver.

The Watchman wait may be over. An analysis of long-term data found the Watchman left atrial appendage closure device to be superior to warfarin for primary efficacy and mortality.

Patients with paroxysmal atrial fibrillation (AF) were less likely to receive guideline recommended anticoagulation therapy compared with persistent AF patients. The analysis presented May 8 at the Heart Rhythm Society scientific sessions in Denver included registry data on more than 62,000 patients.

UnitedHealth Group and the Minneapolis Heart Institute Foundation, in conjunction with Allina Health and the community of New Ulm, Minn., recently announced two grants from the company totaling more than $1 million. The grants will fund weight management and nutrition initiatives for Hearts Beat Back: The Heart of New Ulm Project (HONU), a research and demonstration project with a goal of reducing heart attacks in New Ulm, Minn.

Royal Philips Electronics (NYSE: PHG, AEX: PHI), today announced the completion of patient enrollment in the CHILL-MI clinical study designed to further evaluate the safety and effectiveness of the company’s InnerCool RTx endovascular cooling system in patients with ST-elevation myocardial infarction (STEMI).  

Four research centers will develop high-impact culturally tailored interventions aimed at lowering stroke risk among racial and ethnic minorities in the United States. Together the centers are expected to receive $40 million in funding over five years, contingent on the availability of funds from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.